Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Contemp Clin Trials. 2021 Jan 24;102:106289. doi: 10.1016/j.cct.2021.106289

Table 2.

I Can! study measures. All measures are collected at baseline, 3, 6, and 12 months, excepted where noted.

Primary aims

Objective Processing Speed               Oral Symbol Digit Test from the NIH Toolbox Cognition measures [64,65]
Self-reported Cognition               PROMIS Cognitive Function Measure [66]

Secondary Aims

Psychological Mechanisms          PROMIS Anxiety, Depression, Fatigue, and Physical Functioning Measures for Cancer Survivors [67]
DNA methylation age          Aging-associated DNA methylation profiling, including bi-sulfite sequencing and Illumina Mi-Seq [68]

Dose-Response

Physical Activity & Fitness        7-day, waking hours, hip worn ActiGraph GT3X+ [74,75], 3-min step-test [76], 30-s sit-to-stand test [77]

Other relevant measures

Height & weight Digital scale & stadiometer (height baseline only)
Demographics (baseline only) Age, education, income, race, and marital status with standard surveys
Clinical Chart reviews for date of diagnosis, stage at diagnosis, cancer treatments, date of end of active treatment, hormonal therapy, ER, PR, and HER2 status, and current medications. (baseline only)
Self-report of medical history (baseline and 12 months only)
Memory domain Hopkins Verbal Learning Test-Revised [79], NIH Toolbox Picture Sequence Memory Test & List Sorting Working Memory Test [65]
Executive Functioning domain Trail Making Test [80] & NIH Toolbox Dimensional Change Card Sort Test [65]
Attention domain NIH Toolbox Flanker Inhibitory Control and Attention Test [65] & Conners’ Continuous Performance Test 3 (CPT-3) [81]
Crystalized cognitive ability National Adult Reading Test [82] (baseline only)
Quality of Life PROMIS Sleep-related Impairment [83] and General Self-efficacy [84]; Cognitive and Affective Mindfulness Scale-Revised [85]